A comprehensive diagnostic offering workflow increases the rate of actionable results of the 23- and 35-gene expression profile tests for use as ancillary diagnostic tools for difficult-to-diagnose melanocytic lesions

Main Article Content

Matthew Goldberg
Jennifer Siegel
Brooke Russell
Jason Rogers
Kyle Covington
Kristen Oelschlanger
Trisha Poteet
Jeffrey Wilkinson
Michael Berg
Katherine Falkowski
Sarah Kurley
Armineh Kajoian

Keywords

melanocytic lesion, GEP

Abstract

N/A

References

1. Shoo, B. A. et al. J Am Acad Dermatol 2010. 62 (5) 751–756.

2. Gerami, P. et al. Am J Surg Pathol 2010. 34 (6) 816–821.

3. Haws, B. et al. J Cutan Pathol 2012. 39 (9) 844–849.

4. Elmore, J. G. et al. BMJ 2017. 357 (1) j2813.

5. Clarke, L. E. et al. J Cutan Pathol 2015. 42 (4) 244–252.

6. Clarke, L. E. et al. Cancer 2017. 123 (4) 617–628.

7. Estrada, S. et al. SKIN 2020. 4 (6) 506–522.

8. Ko, J. S. et al. Cancer Epidem Biomar Prev 2017. 26 (7) 1107–1113.

9. Ko, J. S. et al. Human Pathology 2019. 86 213–221.

10. Clarke, L. E. et al. Personalized Medicine 2020. 17 (5) 361–371.

11. Cockerell, C. J. et al. Medicine 2016. 95 (40) e4887.

12. Minca, E. C. et al. Mod Pathol 2016. 29 (8) 832–843.

13. Castillo, S. A. et al. Am J Dermatopathol 2020. 42 (12) 939-947.

14. Farberg, A. et al. SKIN 2020. 4 (6) 523–533.

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 > >>